Zepbound vs Compounded Tirzepatide
Zepbound is FDA-approved tirzepatide labeled for chronic weight management. Compounded tirzepatide supports metabolic optimization where provider-tuned titration or supply continuity is clinically preferred.
Branded Zepbound is appropriate when fixed-pen titration aligns with the candidate.
Compounded tirzepatide is appropriate when titration flexibility or continuity is provider-reviewed as optimal.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Are weight outcomes equivalent?
Outcomes track adherence and titration under provider review.
What if supply changes?
Formulation availability may evolve; candidacy decisions remain unchanged.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment